ValiRx plc (LON:VAL – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 0.76 ($0.01). ValiRx shares last traded at GBX 0.80 ($0.01), with a volume of 36,173,836 shares trading hands.
ValiRx Price Performance
The stock has a market cap of £1.22 million, a price-to-earnings ratio of -46.25 and a beta of 0.59. The company has a 50 day simple moving average of GBX 1.08 and a 200-day simple moving average of GBX 1.74. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.49.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- There Are Different Types of Stock To Invest In
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is Short Interest? How to Use It
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Overbought Stocks Explained: Should You Trade Them?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
